Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.
Read Full NewsIn a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.
A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
1.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
2.
A three-quarters reduction in the risk of prostate cancer is associated with an annual increase in cardiorespiratory fitness of more than three percent.
3.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
4.
Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer
5.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
1.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
2.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
3.
Hope in Numbers: Understanding AML Leukemia Survival Rates and Emerging Therapies
4.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
5.
Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part IX
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge